Prognostic efficacy and prognostic factors of TACE plus TKI with ICIs for the treatment of unresectable hepatocellular carcinoma: A retrospective study.

Han, Ziqiang; Yang, Faji; Zhang, Ye; Wang, Jianlu; Ni, Qingqiang; Zhu, Huaqiang; Zhou, Xu; Gao, Hengjun; Lu, Jun

Han, Ziqiang; Yang, Faji; Zhang, Ye; Wang, Jianlu; Ni, Qingqiang; Zhu, Huaqiang; Zhou, Xu; Gao, Hengjun; Lu, Jun.

Afiliação

Han Z; Department of Hepatobiliary Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
Yang F; Department of Hepatobiliary Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zhang Y; Department of Hepatobiliary Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
Wang J; Department of Hepatobiliary Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
Ni Q; Department of Hepatobiliary Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zhu H; Department of Hepatobiliary Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zhou X; Department of Hepatobiliary Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
Gao H; Department of Hepatobiliary Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
Lu J; Department of Hepatobiliary Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.

Front Oncol ; 12: 1029951, 2022.

Article em En | MEDLINE | ID: mdl-36591442

Palavras-chave

hepatocellular carcinoma; immune checkpoint inhibitor; prognosis; transcatheter arterial chemoembolization; tyrosine kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google